Skip to main content Skip to main navigation menu Skip to site footer

Implications of VP-Shunt, Sodium Level, Glucose Level Ratio and Neurologic Deficit as Clinical Outcome Prognostic Factor in Adult Meningitis Tuberculosis with Acute Hydrocephalus in Dr. Hasan Sadikin General Hospital


Introduction: Meningitis is the most severe and dangerous complication of tuberculosis, and can be fatal if not treated adequately. Acute hydrocephalus is often accompanied by tuberculous meningitis. This study aims to assess the prognostic factors in adult patients with tuberculous meningitis accompanied by hydrocephalus.

Methods: The study was conducted retrospectively by collecting data from the medical records of patients with TB meningitis. Patient data were collected and analyzed using multiple logistic regression to obtain significant prognostic factors.

Result: Fifty-four patients had Grade II TB meningitis and 42 patients had Grade III TB meningitis. In this study, it was found that patients with Grade III had higher mortality than patients with Grade II, especially within 30 days of treatment (HR = 3.73 (2.02-6.89), p<0.0001). In patients with Grade II, low sodium levels increased the risk of mortality compared to near-normal sodium levels (HR = 4.22 (1.44-12.43), p = 0.0088). In patients with Grade III, VP-shunt action reduced the risk of mortality (HR = 0.23 (0.09-0.55), p = 0.0011). Meanwhile, the ratio of glucose levels and neurological deficits was not significant as a prognostic factor (p>0.05).

Conclusions: Patients with grade III TB meningitis generally have a high risk of mortality and require VP-Shunt intervention to increase life expectancy. In patients with grade II tuberculous meningitis, sodium level plays a role in determining the prognosis.


  1. World Health Organization. Global Tuberculosis Report 2021. Geneva: WHO Press
  2. Wang MG, Luo L, Zhang Y, Liu X, Liu L, He JQ. Treatment outcomes of tuberculous meningitis in adults: a systematic review and meta-analysis. BMC Pulm Med 2019; 19(1): 200.
  3. Waecker NJ. Tuberculous meningitis in children. Curr Treat Options Neurol 2002; 4:249-257.
  4. Wilkinson RJ. Tuberculous meningitis. Nat rev Neurol 2017; 3:581-598.
  5. Davis A, Meintjes G, Wilkinson RJ. Treatment of tuberculous meningitis and its complication in adults. Curr Treat Options Neurol 2018; 20(3): 5.
  6. Iype T. Predictors of mortality in patients with meningeal tuberculosis. Neurology India 2012; 60:18-22.
  7. Raut T, Garg RK, Jain A, Hydrocephalus in tuberculous meningitis: incidence, its predictive factors and impact on the prognosis. J Infect 2013; 66:330-337.
  8. Chan KH, Cheung RTF, Fong CY, Clinical relevance of hydrocephalus as a presenting feature of tuberculous meningitis. QJ Med 2003; 96:643-648.
  9. Van Laarhoven A, Dian S, Ruesen C, Hayati E, Damen MSMA, Annisa J, et al. Clinical parameters, routine inflammatory markers, and LTA4H genotype as predictors of mortality among 608 patients with tuberculous meningitis in Indonesia. J Infect Dis 2017; 215(7): 1029-1039.
  10. Singh AK, Malhotra HS, Garg RK, Jain A, Kumar N, Kohli N, et al. Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis. BMC Infect Dis 2016; 16(1): 306.
  11. Dian S, Hermawan R, Van Laarhoven A, Immaculata S, Achmad TH, Ruslami R, et al. Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitis. PLoS ONE 2020; 5(11): e0241974.
  12. Rajshekhar V. Management of hydrocephalus in patients with tuberculous meningitis. Neurol India 2009; 57:368-74.
  13. Be NA, Kim KS, Bishai WR, Pathogenesis of central nervus system tuberculosis. Curr Mol Med 2009; 9:94-99.
  14. Thwaites GE, Lan NTN, Dung NH, Quy HT, Oanh DTT, Thoa NTC, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192(1): 79-88.
  15. Rock RB, Olin M, Baker CA, Central Nervous System Tuberculosis: Pathogenesis and Clinical Aspects. Clin Microbiol rev 2008; 21(2) :243-261.
  16. Palur R, Rajshekhar V, Chandy MJ, Shunt surgery for hydrocephalus in tuberculous meningitis: a long term follow up study. J Neurosurg 1991; 74:64-69.
  17. Srikantha U, Morab JV, Sastry S. Outcome of ventriculoperitoneal shunt placement in grade IV tubercular meningitis with hydrocephalus: a retrospective analysis in 95 patients. J Neurosurg Pediatr 2009; 4:176-183.
  18. Modi M, Sharma K, Prabhakar S, Goyal MK, Takkar A, Sharma N, Garg A, Faisal S, Khandelwal N, Singh P, Sachdeva J, Shree R, Rishi V, Lai V. Clinical and radiological predictors of outcome in tubercular meningitis: a prospective study of 209 patients. Clin Neurol Neurosurg 2017; 161: 29-34.
  19. Nataprawira HM, Ruslianti V, Solek P, Hawani D, Milanti M, Anggraeni R, Memed FS, Kartika A. Outcome of tuberculous meningitis in children: the first comprehensive retrospective cohort study in Indonesia. Int J Tuberc Lung Dis 2016; 20(7): 909-914.
  20. Ruslami R, Ganiem AR, Dian S, Apriani L, Achmad TH, van der Ven AJ, Borm G, Aarnoutse RE, van Crevel R. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open label, randomised controlled phase 2 trial. Lancet Infect Dis 2013; 13(1): 27-35.

How to Cite

Ivanmorl Ruspanah, Yulius Hermanto, Yuniasih MJ Taihuttu, Andrew Ruspanah, Achmad Adam, & Akhmad Imron. (2022). Implications of VP-Shunt, Sodium Level, Glucose Level Ratio and Neurologic Deficit as Clinical Outcome Prognostic Factor in Adult Meningitis Tuberculosis with Acute Hydrocephalus in Dr. Hasan Sadikin General Hospital. Bali Medical Journal, 11(2), 715–719.




Search Panel